InsidersTradesSigma
Track the 삼아제약 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 삼아제약 has published 1 reports. Market capitalisation: €83.6bn. The latest transaction was filed on 11 March 2026 (Other). Among the most active insiders: 삼아제약. All data is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.